HHTM

Oticon Medical has announced the U.S. Food and Drug Administration (FDA) clearance and CE mark approval for its first active transcutaneous bone conduction hearing system, the Sentio System. This new system offers the established benefits of the Ponto™ System and introduces a transcutaneous option. The Sentio System consists of the Sentio 1 Mini, an external sound processor, and the Sentio

A groundbreaking study recently published in Audiology and Neurotology presents a novel application of synchrotron radiation phase-contrast imaging (SR-PCI) to examine cochlear otosclerosis. This advanced imaging technique has enabled researchers to visualize otosclerotic lesions in unprecedented detail, offering new insights into the pathology and potential treatment avenues for this common cause of acquired hearing loss. Otosclerosis Otosclerosis is a bone

Tamra Dale, a former finance executive and now a dedicated stay-at-home mother, shares her challenging journey with hearing loss and its impact on her family life. Tamra first noticed her hearing difficulties in her early 30s, which led her to seek professional help. Despite initial setbacks with inadequate professional support and suboptimal hearing aids, her determination to stay present for

MILAN, ITALY – Amplifon, a global leader in hearing solutions and services, has adopted the EcoVadis platform to assess and support the continuous improvement of its suppliers’ environmental, social, and governance (ESG) practices. This initiative aligns with Amplifon’s sustainable procurement strategy and its Sustainability Plan, which targets achieving a 100% ESG rating for direct suppliers and 50% for indirect suppliers

by Michael Piskosz & Bill Schiffmiller Don’t worry, this isn’t another article that will barrage you with tinnitus statistics, facts, and figures. We see them non-stop and there are plenty of places to find them. Let’s be honest—these figures are nothing more than technical talking points that have very little influence on the real problem. These statistics don’t move the

MONTEPELLIER, FRANCE – Sensorion, a clinical-stage biotechnology company focused on developing novel therapies for hearing loss, has announced new positive data from its SENS-401 Phase 2a clinical trial aimed at preserving residual hearing in adult patients following cochlear implantation. Presented at the 17th International Conference on Cochlear Implants and Other Implantable Technologies (CI2024) in Vancouver, Canada, by Professor Stephen O’Leary,

Host Andrew Bellavia is joined by U.S. sprint kayak champion and Olympic athlete Aaron Small, who has recently been named a Global Brand Ambassador for Phonak. As he prepares to compete in the 2024 Olympics in Paris later this month, Aaron shares his journey of overcoming hearing loss challenges, balancing a rigorous training schedule, and excelling academically. In their candid

TEL AVIV, ISRAEL — Bettear, a company specializing in assistive listening technology, has announced the release of its new Auracast™ products: the B-CASTER streamer and B-RTX transceiver. These devices aim to improve how people experience audio in public spaces such as museums, theaters, and convention centers. “Our commitment to inclusive solutions is reflected in the B-CASTER and B-RTX. We believe

BOSTON, MASSACHUSSETTS – A newly updated study by researchers from the University of Colorado and the University of Pretoria (South Africa) reveals that self-fitting over-the-counter (OTC) hearing aids provide long-term benefits comparable to audiologist-fitted devices at a significantly lower cost. The findings, published today in the Journal of the American Medical Association (JAMA) – Otolaryngology–Head & Neck Surgery, indicate that

DURHAM, NORTH CAROLINA – Global hearing implant leader MED-EL and leading hearing innovator in technology Starkey announced today a collaboration that will enable an all-new Bluetooth listening experience for people with a MED-EL cochlear implant (CI) and Starkey products. The announcement was made at CI2024, the 17th International Conference on Cochlear Implants and Other Implantable Technologies, in Vancouver. The collaboration marks the beginning of